| TP53 | lymphoblastoid cells | Doxo | Permissive
      
      Robust | Homo sapiens | GSE46991
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | lymphoblastoid cells | vehicle | Permissive | Homo sapiens | GSE46991
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | lymphoblastoid cells | nutlin-3 | Permissive | Homo sapiens | GSE46992
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | lymphoblastoid cells | ionizing radiation | Permissive
      
      Robust | Homo sapiens | GSE46993
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | BJ (fibroblasts) | p53 KO | Permissive | Homo sapiens | GSE20076
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | embryonic stem cells | untreated | Permissive
      
      Robust | Mus musculus | GSE26361
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | embryonic stem cells | adriamycin | Permissive
      
      Robust | Mus musculus | GSE26361
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | embryonic stem cells | untreated | Permissive
      
      Robust | Mus musculus | GSE26361
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | embryonic stem cells | adriamycin | Permissive
      
      Robust | Mus musculus | GSE26361
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | embryonic fibroblasts | 0.2ug/ml doxorubicin for 6h | Permissive
      
      Robust | Mus musculus | GSE46240
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | embryonic fibroblasts | 0.2ug/ml doxorubicin for 6h | Permissive | Mus musculus | GSE46240
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | BJ (fibroblasts) | none | Permissive
      
      Robust | Homo sapiens | GSE55912
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | BJ (fibroblasts) | ionizing radiation | Permissive
      
      Robust | Homo sapiens | GSE55912
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | mock | Permissive | Mus musculus | GSE71175
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | 4h 7Gy | Permissive | Mus musculus | GSE71175
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | spleen non-B-cells | mock | Permissive | Mus musculus | GSE71175
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | spleen non-B-cells | 4h 7Gy | Permissive | Mus musculus | GSE71175
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | spleen | 4h 7Gy | Permissive | Mus musculus | GSE71175
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | irradiation 0h | Permissive
      
      Robust | Homo sapiens | GSE100099
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | irradiation 1h | Permissive
      
      Robust | Homo sapiens | GSE100099
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | irradiation 2.5h | Permissive
      
      Robust | Homo sapiens | GSE100099
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | irradiation 4h | Permissive
      
      Robust | Homo sapiens | GSE100099
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | irradiation 5h | Permissive
      
      Robust | Homo sapiens | GSE100099
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | irradiation 7.5h | Permissive
      
      Robust | Homo sapiens | GSE100099
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | irradiation 7.5h + Nutlin | Permissive
      
      Robust | Homo sapiens | GSE100099
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | 400 ng/mL neocarzinostatin for 3 h | Permissive
      
      Robust | Homo sapiens | GSE101737
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | untreated | Permissive
      
      Robust | Homo sapiens | GSE101737
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF-7 C4-12 (invasive breast ductal carcinoma) | 400 ng/mL neocarzinostatin for 3 h | Permissive
      
      Robust | Homo sapiens | GSE101737
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | untreated | Permissive
      
      Robust | Homo sapiens | GSE101737
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | SW480 (colon adenocarcinoma) | TNF-alpha 0 h | Permissive | Homo sapiens | GSE102796
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | SW480 (colon adenocarcinoma) | TNF-alpha 16 h | Permissive | Homo sapiens | GSE102796
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 1/1000 vol. EtOH | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 1/1000 vol. EtOH | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 1/1000 vol. EtOH | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 1/1000 vol. EtOH | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 100nM OHT | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 100nM OHT | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 100nM OHT | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Trp53KI/∆ lymphomas, 2hrs 100nM OHT | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas | Permissive
      
      Robust | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas | Permissive
      
      Robust | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O | Permissive
      
      Robust | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O | Permissive
      
      Robust | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1/1000 vol. H2O | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO | Permissive
      
      Robust | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 0.5/1000 vol. DMSO | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (+)-Nutlin | Permissive
      
      Robust | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (+)-Nutlin | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (+)-Nutlin | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1µM doxorubicin | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1µM doxorubicin | Permissive
      
      Robust | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 1µM doxorubicin | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (-)-Nutlin | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (-)-Nutlin | Permissive | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | B-cells | lymph nodes from Eμ-myc Arf-/- Trp53+/+ lymphomas, 3hrs 5µM (-)-Nutlin | Permissive
      
      Robust | Mus musculus | GSE80186
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE86164
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) | Nutlin | Permissive
      
      Robust | Homo sapiens | GSE86164
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE86164
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | Nutlin | Permissive
      
      Robust | Homo sapiens | GSE86164
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | SJSA-1(osteosarcoma) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE86164
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | SJSA-1(osteosarcoma) | Nutlin | Permissive
      
      Robust | Homo sapiens | GSE86164
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | E14TG2a.4 (embryonic stem cells) | Recombinant human Activin A (R&D Systems, 338-AC) were used at 50ng/ml. | Permissive
      
      Robust | Mus musculus | GSE70486
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | E14TG2a.4 (embryonic stem cells) | SB431542 (Tocris, #1614) were used at 10μM | Permissive
      
      Robust | Mus musculus | GSE70486
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | bone marrow-derived macrophages | irradiated with 6Gy IR for 0h | Permissive | Mus musculus | GSE100962
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | bone marrow-derived macrophages | irradiated with 6Gy IR for 0.5h | Permissive | Mus musculus | GSE100962
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | bone marrow-derived macrophages | irradiated with 6Gy IR for 1h | Permissive | Mus musculus | GSE100962
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | bone marrow-derived macrophages | irradiated with 6Gy IR for 2h | Permissive | Mus musculus | GSE100962
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | bone marrow-derived macrophages | irradiated with 6Gy IR for 6h | Permissive
      
      Robust | Mus musculus | GSE100962
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | Treatment: Decitabine; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#45 | Permissive | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #45 | Permissive
      
      Robust | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #45 | Permissive
      
      Robust | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#90 | Permissive | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #90 | Permissive
      
      Robust | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #90 | Permissive
      
      Robust | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#104 | Permissive | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #104 | Permissive
      
      Robust | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 10 uM Nutlin-3 for 24 hrs Source: healthy volunteer #104 | Permissive
      
      Robust | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 0.1% DMSO for 24 hrs Source: healthy volunteer#116 | Permissive
      
      Robust | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | PHA-simulated human T-lynphocytes | Treatment: 0.3 ug/ml Doxorubicin for 24 hrs Source: healthy volunteer #116 | Permissive
      
      Robust | Homo sapiens | GSE110368
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | Treatment: untreated control Sex: female Age:15 years Tissue: bone | Permissive | Homo sapiens | GSE110800
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | Treatment:2hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone | Permissive | Homo sapiens | GSE110800
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | Treatment:4hr after irradiation with 10Gy (1Gy/min) Sex: female Age:15 years Tissue: bone | Permissive | Homo sapiens | GSE110800
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | Treatment: etoposide (100uM, 6hrs) Source: IMR90 fetal lung fibroblasts Passage: #30-35 | Permissive
      
      Robust | Homo sapiens | GSE115940
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | SW480 (colon adenocarcinoma) | treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable control (LacZ) knockdown | Permissive | Homo sapiens | GSE115985
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | SW480 (colon adenocarcinoma) | treatment: TNF for 16hr Celltype: colon cancer cells Genotype: stable p53 knockdown | Permissive | Homo sapiens | GSE115985
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | HIV-1 latently-infected central memory T cells cultured from uninfected primary T cells | Treatment: no treatment, control | Permissive | Homo sapiens | GSE83317
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | LOXIMVI | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | UO31 | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | A498 | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | Treatment: 4GY for 2hrs; | Permissive | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | SK-MEL-5 (Cutaneous melanoma) | Treatment: 4GY for 2hrs; | Permissive | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MALME3 | Treatment: 4GY for 2hrs; | Permissive | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | NCI-H460 (Large cell lung carcinoma) | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | A549 (lung carcinoma) | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | UACC62 | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | UACC257 | Treatment: 4GY for 2hrs; | Permissive | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | UACC257 | Treatment: 4GY for 2hrs; | Permissive
      
      Robust | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | RPE | Treatment: 4GY for 2hrs; | Permissive | Homo sapiens | GSE100292
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | Treatment: DMSO for 6hrs; Passage: 30-35; | Permissive
      
      Robust | Homo sapiens | GSE58740
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | Treatment: nutlin3a (5uM final) for 6hrs; Passage: 30-35; | Permissive
      
      Robust | Homo sapiens | GSE58740
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | foreskin fibroblast | Treatment: DMSO for 6 hrs; | Permissive
      
      Robust | Homo sapiens | GSE111009
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | foreskin fibroblast | Treatment: 5 uM Nutlin3A for 6 hrs; | Permissive
      
      Robust | Homo sapiens | GSE111009
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF10A (breast epithelial cells) | Treatment: DMSO for 6 hrs; | Permissive
      
      Robust | Homo sapiens | GSE111009
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF10A (breast epithelial cells) | Treatment: 5 uM Nutlin3A for 6 hrs; | Permissive
      
      Robust | Homo sapiens | GSE111009
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | foreskin fibroblast | Treatment: DMSO for 6 hrs; | Permissive | Homo sapiens | GSE111009
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | NMuMG (mammary epithelial cells) | Treatment: not treated, not infectred; | Permissive
      
      Robust | Mus musculus | GSE87002
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | NMuMG (mammary epithelial cells) | Treatment: 0.5 uM  Adriamycin for 8hrs, not infectred; | Permissive
      
      Robust | Mus musculus | GSE87002
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | NMuMG (mammary epithelial cells) | Treatment: not treated, infected with L-pWPI empy vector; | Permissive | Mus musculus | GSE87002
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | NMuMG (mammary epithelial cells) | Treatment: not treated, infected with L-pWPI-MycER; | Permissive | Mus musculus | GSE87002
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) | NUT | Permissive
      
      Robust | Homo sapiens | GSE47041 | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) | IR | Permissive | Homo sapiens | GSE60267 | MA0106.3 | 
  
    
    | TP53 | E15.5 embryonic kidney |  | Permissive | Mus musculus | GSE49916
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | BJ (fibroblasts) |  | Permissive | Homo sapiens | GSE20076
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | fibroblasts |  | Permissive | Homo sapiens | GSE36749
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MDA-MB-231 (breast adenocarcinoma) |  | Permissive | Homo sapiens | GSE66543
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MDA231-LM2-4175 (breast adenocarcinoma) |  | Permissive | Homo sapiens | GSE95303
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | MCF7 (Invasive ductal breast carcinoma) |  | Permissive | Homo sapiens | GSE109481
              
            
          
            
            ... | MA0106.3 | 
  
    
    | TP53 | SaOS2 (osteosarcoma) |  | Permissive | Homo sapiens | ERP002038 | MA0106.3 | 
  
    
    | TP53 | NCI-H1299 (large cell lung carcinoma) |  | Permissive | Homo sapiens | ERP022459 | MA0106.3 | 
  
    
    | TP53 | SaOS2 (osteosarcoma) |  | Permissive
      
      Robust | Homo sapiens | GSE15780 | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | GSE31558 | MA0106.3 | 
  
    
    | TP53 | H9 |  | Permissive | Homo sapiens | GSE39912 | MA0106.3 | 
  
    
    | TP53 | SaOS2 (osteosarcoma) |  | Permissive | Homo sapiens | GSE51268 | MA0106.3 | 
  
    
    | TP53 | GM00011 (fetal skin fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | GSE55727 | MA0106.3 | 
  
    
    | TP53 | GM06170 (fetal skin fibroblasts) |  | Permissive
      
      Robust | Homo sapiens | GSE55727 | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE58714 | MA0106.3 | 
  
    
    | TP53 |  |  | Permissive | Homo sapiens | GSE59176 | MA0106.3 | 
  
    
    | TP53 |  |  | Permissive | Homo sapiens | GSE59176 | MA0106.3 | 
  
    
    | TP53 |  |  | Permissive
      
      Robust | Homo sapiens | GSE59176 | MA0106.3 | 
  
    
    | TP53 |  |  | Permissive | Homo sapiens | GSE59176 | MA0106.3 | 
  
    
    | TP53 | HepG2 (hepatoblastoma) |  | Permissive | Homo sapiens | GSE64877 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | UV_16H | Permissive
      
      Robust | Homo sapiens | ERP004176 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | UV_8H | Permissive
      
      Robust | Homo sapiens | ERP004176 | MA0106.3 | 
  
    
    | TP53 |  | NUT | Permissive
      
      Robust | Homo sapiens | ERP014035 | MA0106.3 | 
  
    
    | TP53 |  | TPA_24H | Permissive | Homo sapiens | ERP014035 | MA0106.3 | 
  
    
    | TP53 |  | TPA_4H | Permissive | Homo sapiens | ERP014035 | MA0106.3 | 
  
    
    | TP53 | hESC-1 (Embryonic stem cells) | DAMAGED | Permissive
      
      Robust | Homo sapiens | GSE39912 | MA0106.3 | 
  
    
    | TP53 | hESC-1 (Embryonic stem cells) | DIFF | Permissive | Homo sapiens | GSE39912 | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | SENES_SHLUC | Permissive | Homo sapiens | GSE42728 | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | SENES_SHP53 | Permissive | Homo sapiens | GSE42728 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE46641 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | DXR | Permissive
      
      Robust | Homo sapiens | GSE46641 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | NUT | Permissive
      
      Robust | Homo sapiens | GSE46641 | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | APO | Permissive | Homo sapiens | GSE53491 | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | SENE | Permissive | Homo sapiens | GSE53491 | MA0106.3 | 
  
    
    | TP53 | keratinocytes | ADRIA | Permissive
      
      Robust | Homo sapiens | GSE56674 | MA0106.3 | 
  
    
    | TP53 | keratinocytes | CISP | Permissive
      
      Robust | Homo sapiens | GSE56674 | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) | 5FU | Permissive
      
      Robust | Homo sapiens | GSE58506 | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | DMSO | Permissive
      
      Robust | Homo sapiens | GSE58740 | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) | NUT3A | Permissive
      
      Robust | Homo sapiens | GSE58740 | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) | CAMP | Permissive | Homo sapiens | GSE74355 | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) | DMSO_KOATF3 | Permissive
      
      Robust | Homo sapiens | GSE74355 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) |  | Permissive | Homo sapiens | ERP004176 | MA0106.3 | 
  
    
    | TP53 |  |  | Permissive | Homo sapiens | ERP014035 | MA0106.3 | 
  
    
    | TP53 | IMR90 (lung fibroblasts) |  | Permissive | Homo sapiens | GSE42728 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) |  | Permissive | Homo sapiens | GSE46641 | MA0106.3 | 
  
    
    | TP53 | keratinocytes |  | Permissive
      
      Robust | Homo sapiens | GSE56674 | MA0106.3 | 
  
    
    | TP53 | HCT-116 (colon carcinoma) |  | Permissive
      
      Robust | Homo sapiens | GSE58506 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | ETO | Permissive
      
      Robust | Homo sapiens | GSE21939 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | ACTD | Permissive
      
      Robust | Homo sapiens | GSE21939 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | ACTD | Permissive
      
      Robust | Homo sapiens | GSE21939 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | ACTD | Permissive | Homo sapiens | GSE21939 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | ETO | Permissive
      
      Robust | Homo sapiens | GSE21939 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | ETO | Permissive
      
      Robust | Homo sapiens | GSE21939 | MA0106.3 | 
  
    
    | TP53 | U2OS (osteosarcoma) | ETO | Permissive
      
      Robust | Homo sapiens | GSE21939 | MA0106.3 |